TITLE

Transdermal Absorption of Nitroglycerin from Microseal Drug Delivery (MDD) System

AUTHOR(S)
Karim, Aziz
PUB. DATE
January 1983
SOURCE
Angiology;Jan1983, Vol. 34 Issue 1, p11
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A recent important advance in biopharmaceutics has been the utilization of controlled delivery of drugs to the systemic circulation through the intact skin. With the conventional tablet and capsule dosage forms, the amount of drug absorbed through the gastrointestinal (GI) tract varies depending on the quantity and types of food in the stomach, on the GI motility and transit time. Acid and/or alkaline labile drugs may be deactivated prior to absorption from the GI tract while some drugs also get deactivated by GI microbial flora. In the case of drugs with a high hepatic extraction ratio, the absorbed drug may be largely deactivated by first-pass metabolism before reaching the systemic circulation. Drug absorption through the GI tract can therefore result in variable and/or unpredictable blood levels. Some of this variability can be minimized by administering controlled-release tablet or capsule formulations. However, these dosage forms cannot eliminate the inherent variability associated with first-pass metabolism.
ACCESSION #
16438429

 

Related Articles

  • The Clinical Use of Transdermal Delivery Devices with Nitroglycerin. Thompson, Richard H. // Angiology;Jan1983, Vol. 34 Issue 1, p23 

    Eleven patients entered a double-blind, cross-over study that compared the influence of a new transdermal preparation of nitroglycerin (Nitrodisc: MDD-NG, Searle Limited) on exercise performance with the influence of placebo. Eight patients have completed the study. All patients had severe...

  • EVALUATION OF NITROGLYCERIN SUSTAIN RELEASE FROM A MICRORESERVOIR TRANSDERMAL PATCH. ALIREZA, JANFADA; JAVAD, TAVAKOLI // Asian Journal of Pharmaceutical & Clinical Research;Supplement 5, Vol. 6, p191 

    Achieving a systemic effect of a drug by delivery through skin is commonly known as transdermal drug delivery and differs from traditional topical drug delivery. The development of transdermal drug delivery systems is a multidisciplinary activity that encompasses fundamental feasibility studies...

  • Transdermal Patch Drug Delivery Interactions with Exercise. Lenz, Thomas L.; Gillespie, Nicole // Sports Medicine;2011, Vol. 41 Issue 3, p177 

    Transdermal drug delivery systems, such as the transdermal patch, continue to be a popular and convenient way to administer medications. There are currently several medications that use a transdermal patch drug delivery system. This article describes the potential untoward side effects of...

  • Transdermal Nitroglycerin Delivery Using Acrylic Matrices: Design, Formulation, and In Vitro Characterization. Savoji, Houman; Mehdizadeh, Amir; Saadat Abadi, Ahmad Ramazani // ISRN Otolaryngology;2014, p1 

    Nitroglycerin (TNG) transdermal drug delivery systems (TDDSs) with different acrylic pressure-sensitive adhesives (PSAs) and chemical permeation enhancers (CPEs) were prepared. The effects of PSAs and CPEs types and concentrations on skin permeation and in vitro drug release from devices were...

  • Drug Dispensers. Perros, George // Paper, Film & Foil Converter;Oct2003, Vol. 77 Issue 10, p49 

    Discusses the opportunities offered by transdermal patches for companies that manufacture drug patches and their supply chain partners. Components of transdermal delivery system; Major market driver for the over-the-counter patch; Types of transdermal delivery system products; Emerging and...

  • Developing Custom Adhesive Systems for Transdermal Drug Delivery Products. Hopp, Melinda S. // Pharmaceutical Technology North America;Mar2002, Vol. 26 Issue 3, p30 

    Looks into the market acceptance on the development of adhesive systems for transdermal drug delivery systems in the U.S. Methods of drug administration; Delivery of materials like nicotine for smoking cessation; Challenges for specialty adhesives manufacturers.

  • FORMULATION AND EVALUATION ASPECTS OF TRANSDERMAL DRUG DELIVERY SYSTEM. Patel, Dipen M.; Kavitha, K. // International Journal of Pharmaceutical Sciences Review & Resear;Jan/Feb2011, Vol. 6 Issue 2, p83 

    The conventional oral dosage forms has significant drawbacks of poor bioavailability due to hepatic first pass metabolism and tendency to produce rapid blood level spikes (Both high and low), leading to a need for high and/or frequent dosing, which can be both cost prohibitive and inconvenient....

  • Single and Multiple Dose Pharmacokinetic Evaluation of a Transdermal Delivery System of Imipramine Hydrochloride. Panchagnula, Ramesh; Dravid, Prajakta; Jain, Amit; Khandavilli, Sateesh // Drug Research / Arzneimittel-Forschung (Editio Cantor Verlag fur;Apr2005, Vol. 55 Issue 4, p198 

    The transdermal route provides an at- tractive alternative to the presently used peroral therapy with tricyclic antidepressants due to the avoidance of first-pass metabolism and the associated side effects. In this investigation an earlier developed transdermal delivery system (TDS) of...

  • PENETRATION ENHANCEMENT TECHNOLOGIES FOR TRANSDERMAL DRUG DELIVERY SYSTEMS. Vaghela, Bhavesh; Bhatt, Nayana; Pathak, Nimish; Rathod, Dashrath // International Journal of Pharmaceutical Sciences Review & Resear;Sep/Oct2011, Vol. 10 Issue 1, p130 

    There is considerable interest in the skin as a site of drug application for both local and systemic effect. The transdermal route has numerous advantages over the more traditional drug delivery routes. These include high bioavailability, absence of first pass hepatic metabolism, steady drug...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics